{"originalText": "患者因\\\"体检发现肝占位10天\\\"于2012年1月到我院就诊，经完善检查诊断为结肠腺癌并肝多发转移,无手术禁忌症，于2012-02-06日全麻上行“DIXON'S+肠粘连松解术”，术顺，术后恢复顺利。术后病理示中分化腺癌，浸润至浆膜上，淋巴结3/9转移。于术后3周始返院行FOLFIRI（开普拓+5-FU/CF）化疗8周期，加安维汀7周期。2012-6-20查CT示肝脏各叶可见多发异常密度影，病变较前缩小（最大者由20×31MM缩至15×28MM），病变数目大致同前。多学科讨论决定暂停开普拓及安维汀，继续予5FU/CF维持化疗，结合射频治疗。后患者于2012年7月11日行肝转移瘤射频消融术，术程顺利。现为进一步治疗入住我科，患者精神、饮食、睡眠可，大小便正常，无腹痛、腹胀、恶心、呕吐，体重无明显减轻。", "entities": [{"end_pos": 10, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 39, "end_pos": 49}, {"label_type": "手术", "overlap": 0, "start_pos": 74, "end_pos": 88}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 105, "end_pos": 110}, {"end_pos": 147, "label_type": "药物", "overlap": 0, "start_pos": 144}, {"end_pos": 152, "label_type": "药物", "overlap": 0, "start_pos": 148}, {"end_pos": 155, "label_type": "药物", "overlap": 0, "start_pos": 153}, {"end_pos": 166, "label_type": "药物", "overlap": 0, "start_pos": 163}, {"label_type": "影像检查", "overlap": 0, "start_pos": 180, "end_pos": 182}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}, {"end_pos": 247, "label_type": "药物", "overlap": 0, "start_pos": 244}, {"end_pos": 251, "label_type": "药物", "overlap": 0, "start_pos": 248}, {"end_pos": 258, "label_type": "药物", "overlap": 0, "start_pos": 255}, {"end_pos": 261, "label_type": "药物", "overlap": 0, "start_pos": 259}, {"end_pos": 297, "label_type": "手术", "overlap": 0, "start_pos": 288}, {"end_pos": 335, "label_type": "解剖部位", "overlap": 0, "start_pos": 334}, {"end_pos": 338, "label_type": "解剖部位", "overlap": 0, "start_pos": 337}]}
